Company Filing History:
1 out of 5,076 
1 out of 1 Years Active: 2012
Title: **Eduarda Maria Santos Dores Arala Chaves: Pioneering Research in Immunology**
Introduction
Eduarda Maria Santos Dores Arala Chaves, a distinguished legal representative based in Lisboa, Portugal, has made significant contributions to the field of immunology through his innovative research. With a robust portfolio that includes one patent, he is recognized for his work on methods that enhance immune responses against parasites and viruses.
Latest Patents
Arala Chaves holds a patent titled "Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens." This groundbreaking method provides a strategy for preventing or inhibiting infections caused by parasites or viruses in living organisms. By administering a parasite or virus mitogen in a controlled sub-mitogenic amount, it aims to induce a protective immune response in human patients who are in need of such treatment.
Career Highlights
Throughout his career, Arala Chaves has collaborated with prestigious research institutions, such as the Centre National De La Recherche Scientifique and the Instituto Gulbenkian De Ciência. His academic and professional journey reflects a deep commitment to advancing scientific knowledge and improving public health through innovative medical solutions.
Collaborations
In the pursuit of his research goals, Arala Chaves has worked alongside esteemed colleagues, including Paolo Minoprio and Mario Arala-Chaves. Their collaboration has fostered a rich exchange of ideas and expertise, further enhancing the impact of their collective work in the immunology landscape.
Conclusion
Eduarda Maria Santos Dores Arala Chaves stands as a prominent figure in the field of immunology, with a focus on developing novel methods to combat infectious diseases. His patent and collaborative efforts with leading institutions underscore his dedication to scientific advancement and the enhancement of global health outcomes.